新興国医薬品市場トップ5の概要、競合分析、2018-2027年予測Top 5 Emerging Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 新興国医薬品市場トップ5の概要、競合分析、2018-2027年予測 概要 新興国5ヶ国の医薬品産業プロファイルは、市場シェア、市場規模(2018-22年値、2027年予測)など、トップラインの定性的・定量的サマリー... もっと見る
サマリー新興国医薬品市場トップ5の概要、競合分析、2018-2027年予測概要 新興国5ヶ国の医薬品産業プロファイルは、市場シェア、市場規模(2018-22年値、2027年予測)など、トップラインの定性的・定量的サマリー情報を提供します。また、主要な財務指標や市場内の競争圧力の分析など、主要企業に関する記述も掲載しています。 主要ハイライト - これらの国々は、2022年に世界の医薬品産業に2,882億ドル貢献し、2007年から2011年の年間平均成長率(CAGR)は9.1%であった。新興国上位5カ国は2027年に4,517億ドルに達し、2022〜27年のCAGRは9.4%と予想される。 - 医薬品業界では、新興国上位5カ国の中で中国がトップで、2022年の市場売上は2,132億ドルに達する。次いでメキシコが255億ドル、インドが242億ドルとなっている。 - 中国は2027年に3,552億ドル、次いでメキシコが378億ドル、インドが326億ドルとなり、新興国上位5カ国で医薬品業界をリードすると予想される。 スコープ - 新興5カ国医薬品市場の規模、成長、主要プレイヤーを特定することで、初級レベルの調査にかかる時間を短縮 - ファイブフォース分析により、新興5大医薬品市場の競争力および魅力度を判断 - 主要企業のプロフィールから、新興5大医薬品市場の主要企業の事業および財務実績の詳細を明らかにします。 - 新興5大医薬品市場の今後の成長見通しを5年予測で把握することで、プレゼンテーションやピッチに重みを加えることができます - ブラジル、中国、インド、メキシコ、南アフリカのデータを比較し、それぞれの国について個別の章を設けています。 購入の理由 - 2022年の新興5カ国医薬品市場規模は? - 2027年の新興5大医薬品市場規模は? - 新興5大医薬品市場の競争力に影響を与える要因は何か? - 過去5年間の市場の推移は? - 新興5大医薬品市場における上位競合企業は? 目次Table of Contents1 Introduction 1.1. What is this report about? 1.2. Who is the target reader? 1.3. How to use this report 1.4. Definitions 2 Top 5 Emerging Countries Pharmaceuticals 2.1. Industry Outlook 3 Pharmaceuticals in South Africa 3.1. Market Overview 3.2. Market Data 3.3. Market Segmentation 3.4. Market outlook 3.5. Five forces analysis 4 Macroeconomic Indicators 4.1. Country data 5 Pharmaceuticals in Brazil 5.1. Market Overview 5.2. Market Data 5.3. Market Segmentation 5.4. Market outlook 5.5. Five forces analysis 6 Macroeconomic Indicators 6.1. Country data 7 Pharmaceuticals in China 7.1. Market Overview 7.2. Market Data 7.3. Market Segmentation 7.4. Market outlook 7.5. Five forces analysis 8 Macroeconomic Indicators 8.1. Country data 9 Pharmaceuticals in India 9.1. Market Overview 9.2. Market Data 9.3. Market Segmentation 9.4. Market outlook 9.5. Five forces analysis 10 Macroeconomic Indicators 10.1. Country data 11 Pharmaceuticals in Mexico 11.1. Market Overview 11.2. Market Data 11.3. Market Segmentation 11.4. Market outlook 11.5. Five forces analysis 12 Macroeconomic Indicators 12.1. Country data 13 Company Profiles 13.1. Aspen Pharmacare Holdings Ltd 13.2. Adcock Ingram Holdings Ltd 13.3. Novartis AG 13.4. Ache Laboratorios Farmaceuticos SA 13.5. EMS Sigma Pharma 13.6. Yangtze River Pharmaceutical Group 13.7. Shanghai Pharmaceuticals Holding Co Ltd 13.8. Yunnan Baiyao Group Co Ltd 13.9. Guangzhou Pharmaceutical Holdings Ltd 13.10. Sun Pharmaceutical Industries Ltd 13.11. Lupin Ltd 13.12. Dr. Reddy's Laboratories Limited 13.13. Aurobindo Pharma Ltd 13.14. Sanofi SA 13.15. Genomma Lab Internacional SAB de CV 13.16. Pfizer Inc. 14 Appendix 14.1. Methodology 14.2. About MarketLine 図表リストList of TablesTable 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-27 Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-22 Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2022-27 Table 4: South Africa pharmaceuticals market value: $ billion, 2017-22 Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2022 Table 6: South Africa pharmaceuticals market value forecast: $ billion, 2022–27 Table 7: South Africa size of population (million), 2018–22 Table 8: South Africa gdp (constant 2005 prices, $ billion), 2018–22 Table 9: South Africa gdp (current prices, $ billion), 2018–22 Table 10: South Africa inflation, 2018–22 Table 11: South Africa consumer price index (absolute), 2018–22 Table 12: South Africa exchange rate, 2018–22 Table 13: Brazil pharmaceuticals market value: $ billion, 2017-22 Table 14: Brazil pharmaceuticals market geography segmentation: $ billion, 2022 Table 15: Brazil pharmaceuticals market value forecast: $ billion, 2022–27 Table 16: Brazil size of population (million), 2018–22 Table 17: Brazil gdp (constant 2005 prices, $ billion), 2018–22 Table 18: Brazil gdp (current prices, $ billion), 2018–22 Table 19: Brazil inflation, 2018–22 Table 20: Brazil consumer price index (absolute), 2018–22 Table 21: Brazil exchange rate, 2018–22 Table 22: China pharmaceuticals market value: $ billion, 2017-22 Table 23: China pharmaceuticals market geography segmentation: $ billion, 2022 Table 24: China pharmaceuticals market value forecast: $ billion, 2022–27 Table 25: China size of population (million), 2018–22 Table 26: China gdp (constant 2005 prices, $ billion), 2018–22 Table 27: China gdp (current prices, $ billion), 2018–22 Table 28: China inflation, 2018–22 Table 29: China consumer price index (absolute), 2018–22 Table 30: China exchange rate, 2018–22 Table 31: India pharmaceuticals market value: $ billion, 2017-22 Table 32: India pharmaceuticals market geography segmentation: $ billion, 2022 Table 33: India pharmaceuticals market value forecast: $ billion, 2022–27 Table 34: India size of population (million), 2018–22 Table 35: India gdp (constant 2005 prices, $ billion), 2018–22 Table 36: India gdp (current prices, $ billion), 2018–22 Table 37: India inflation, 2018–22 Table 38: India consumer price index (absolute), 2018–22 Table 39: India exchange rate, 2018–22 Table 40: Mexico pharmaceuticals market value: $ billion, 2017-22 Table 41: Mexico pharmaceuticals market geography segmentation: $ billion, 2022 Table 42: Mexico pharmaceuticals market value forecast: $ billion, 2022–27 Table 43: Mexico size of population (million), 2018–22 Table 44: Mexico gdp (constant 2005 prices, $ billion), 2018–22 Table 45: Mexico gdp (current prices, $ billion), 2018–22 Table 46: Mexico inflation, 2018–22 Table 47: Mexico consumer price index (absolute), 2018–22 Table 48: Mexico exchange rate, 2018–22 Table 49: Aspen Pharmacare Holdings Ltd: key facts Table 50: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios Table 51: Aspen Pharmacare Holdings Ltd: Key Employees Table 52: Adcock Ingram Holdings Ltd: key facts Table 53: Adcock Ingram Holdings Ltd: Annual Financial Ratios Table 54: Adcock Ingram Holdings Ltd: Key Employees Table 55: Novartis AG: key facts Table 56: Novartis AG: Annual Financial Ratios Table 57: Novartis AG: Key Employees Table 58: Novartis AG: Key Employees Continued Table 59: Ache Laboratorios Farmaceuticos SA: key facts Table 60: Ache Laboratorios Farmaceuticos SA: Key Employees Table 61: EMS Sigma Pharma: key facts Table 62: EMS Sigma Pharma: Key Employees Table 63: Yangtze River Pharmaceutical Group: key facts Table 64: Yangtze River Pharmaceutical Group: Key Employees Table 65: Shanghai Pharmaceuticals Holding Co Ltd: key facts Table 66: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios Table 67: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees Table 68: Yunnan Baiyao Group Co Ltd: key facts Table 69: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios Table 70: Guangzhou Pharmaceutical Holdings Ltd: key facts Table 71: Guangzhou Pharmaceutical Holdings Ltd: Key Employees Table 72: Sun Pharmaceutical Industries Ltd: key facts Table 73: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios Table 74: Sun Pharmaceutical Industries Ltd: Key Employees Table 75: Sun Pharmaceutical Industries Ltd: Key Employees Continued Table 76: Lupin Ltd: key facts Table 77: Lupin Ltd: Annual Financial Ratios Table 78: Lupin Ltd: Key Employees Table 79: Dr. Reddy's Laboratories Limited: key facts Table 80: Dr. Reddy's Laboratories Limited: Annual Financial Ratios Table 81: Dr. Reddy's Laboratories Limited: Key Employees Table 82: Aurobindo Pharma Ltd: key facts Table 83: Aurobindo Pharma Ltd: Annual Financial Ratios Table 84: Aurobindo Pharma Ltd: Key Employees Table 85: Sanofi SA: key facts Table 86: Sanofi SA: Annual Financial Ratios Table 87: Sanofi SA: Key Employees Table 88: Sanofi SA: Key Employees Continued Table 89: Genomma Lab Internacional SAB de CV: key facts Table 90: Genomma Lab Internacional SAB de CV: Annual Financial Ratios Table 91: Genomma Lab Internacional SAB de CV: Key Employees Table 92: Pfizer Inc.: key facts Table 93: Pfizer Inc.: Annual Financial Ratios Table 94: Pfizer Inc.: Key Employees Table 95: Pfizer Inc.: Key Employees Continued Table 96: Maypo Farmaceutics SA de CV: key facts
SummaryTop 5 Emerging Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 Table of ContentsTable of Contents1 Introduction 1.1. What is this report about? 1.2. Who is the target reader? 1.3. How to use this report 1.4. Definitions 2 Top 5 Emerging Countries Pharmaceuticals 2.1. Industry Outlook 3 Pharmaceuticals in South Africa 3.1. Market Overview 3.2. Market Data 3.3. Market Segmentation 3.4. Market outlook 3.5. Five forces analysis 4 Macroeconomic Indicators 4.1. Country data 5 Pharmaceuticals in Brazil 5.1. Market Overview 5.2. Market Data 5.3. Market Segmentation 5.4. Market outlook 5.5. Five forces analysis 6 Macroeconomic Indicators 6.1. Country data 7 Pharmaceuticals in China 7.1. Market Overview 7.2. Market Data 7.3. Market Segmentation 7.4. Market outlook 7.5. Five forces analysis 8 Macroeconomic Indicators 8.1. Country data 9 Pharmaceuticals in India 9.1. Market Overview 9.2. Market Data 9.3. Market Segmentation 9.4. Market outlook 9.5. Five forces analysis 10 Macroeconomic Indicators 10.1. Country data 11 Pharmaceuticals in Mexico 11.1. Market Overview 11.2. Market Data 11.3. Market Segmentation 11.4. Market outlook 11.5. Five forces analysis 12 Macroeconomic Indicators 12.1. Country data 13 Company Profiles 13.1. Aspen Pharmacare Holdings Ltd 13.2. Adcock Ingram Holdings Ltd 13.3. Novartis AG 13.4. Ache Laboratorios Farmaceuticos SA 13.5. EMS Sigma Pharma 13.6. Yangtze River Pharmaceutical Group 13.7. Shanghai Pharmaceuticals Holding Co Ltd 13.8. Yunnan Baiyao Group Co Ltd 13.9. Guangzhou Pharmaceutical Holdings Ltd 13.10. Sun Pharmaceutical Industries Ltd 13.11. Lupin Ltd 13.12. Dr. Reddy's Laboratories Limited 13.13. Aurobindo Pharma Ltd 13.14. Sanofi SA 13.15. Genomma Lab Internacional SAB de CV 13.16. Pfizer Inc. 14 Appendix 14.1. Methodology 14.2. About MarketLine List of Tables/GraphsList of TablesTable 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-27 Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-22 Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2022-27 Table 4: South Africa pharmaceuticals market value: $ billion, 2017-22 Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2022 Table 6: South Africa pharmaceuticals market value forecast: $ billion, 2022–27 Table 7: South Africa size of population (million), 2018–22 Table 8: South Africa gdp (constant 2005 prices, $ billion), 2018–22 Table 9: South Africa gdp (current prices, $ billion), 2018–22 Table 10: South Africa inflation, 2018–22 Table 11: South Africa consumer price index (absolute), 2018–22 Table 12: South Africa exchange rate, 2018–22 Table 13: Brazil pharmaceuticals market value: $ billion, 2017-22 Table 14: Brazil pharmaceuticals market geography segmentation: $ billion, 2022 Table 15: Brazil pharmaceuticals market value forecast: $ billion, 2022–27 Table 16: Brazil size of population (million), 2018–22 Table 17: Brazil gdp (constant 2005 prices, $ billion), 2018–22 Table 18: Brazil gdp (current prices, $ billion), 2018–22 Table 19: Brazil inflation, 2018–22 Table 20: Brazil consumer price index (absolute), 2018–22 Table 21: Brazil exchange rate, 2018–22 Table 22: China pharmaceuticals market value: $ billion, 2017-22 Table 23: China pharmaceuticals market geography segmentation: $ billion, 2022 Table 24: China pharmaceuticals market value forecast: $ billion, 2022–27 Table 25: China size of population (million), 2018–22 Table 26: China gdp (constant 2005 prices, $ billion), 2018–22 Table 27: China gdp (current prices, $ billion), 2018–22 Table 28: China inflation, 2018–22 Table 29: China consumer price index (absolute), 2018–22 Table 30: China exchange rate, 2018–22 Table 31: India pharmaceuticals market value: $ billion, 2017-22 Table 32: India pharmaceuticals market geography segmentation: $ billion, 2022 Table 33: India pharmaceuticals market value forecast: $ billion, 2022–27 Table 34: India size of population (million), 2018–22 Table 35: India gdp (constant 2005 prices, $ billion), 2018–22 Table 36: India gdp (current prices, $ billion), 2018–22 Table 37: India inflation, 2018–22 Table 38: India consumer price index (absolute), 2018–22 Table 39: India exchange rate, 2018–22 Table 40: Mexico pharmaceuticals market value: $ billion, 2017-22 Table 41: Mexico pharmaceuticals market geography segmentation: $ billion, 2022 Table 42: Mexico pharmaceuticals market value forecast: $ billion, 2022–27 Table 43: Mexico size of population (million), 2018–22 Table 44: Mexico gdp (constant 2005 prices, $ billion), 2018–22 Table 45: Mexico gdp (current prices, $ billion), 2018–22 Table 46: Mexico inflation, 2018–22 Table 47: Mexico consumer price index (absolute), 2018–22 Table 48: Mexico exchange rate, 2018–22 Table 49: Aspen Pharmacare Holdings Ltd: key facts Table 50: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios Table 51: Aspen Pharmacare Holdings Ltd: Key Employees Table 52: Adcock Ingram Holdings Ltd: key facts Table 53: Adcock Ingram Holdings Ltd: Annual Financial Ratios Table 54: Adcock Ingram Holdings Ltd: Key Employees Table 55: Novartis AG: key facts Table 56: Novartis AG: Annual Financial Ratios Table 57: Novartis AG: Key Employees Table 58: Novartis AG: Key Employees Continued Table 59: Ache Laboratorios Farmaceuticos SA: key facts Table 60: Ache Laboratorios Farmaceuticos SA: Key Employees Table 61: EMS Sigma Pharma: key facts Table 62: EMS Sigma Pharma: Key Employees Table 63: Yangtze River Pharmaceutical Group: key facts Table 64: Yangtze River Pharmaceutical Group: Key Employees Table 65: Shanghai Pharmaceuticals Holding Co Ltd: key facts Table 66: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios Table 67: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees Table 68: Yunnan Baiyao Group Co Ltd: key facts Table 69: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios Table 70: Guangzhou Pharmaceutical Holdings Ltd: key facts Table 71: Guangzhou Pharmaceutical Holdings Ltd: Key Employees Table 72: Sun Pharmaceutical Industries Ltd: key facts Table 73: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios Table 74: Sun Pharmaceutical Industries Ltd: Key Employees Table 75: Sun Pharmaceutical Industries Ltd: Key Employees Continued Table 76: Lupin Ltd: key facts Table 77: Lupin Ltd: Annual Financial Ratios Table 78: Lupin Ltd: Key Employees Table 79: Dr. Reddy's Laboratories Limited: key facts Table 80: Dr. Reddy's Laboratories Limited: Annual Financial Ratios Table 81: Dr. Reddy's Laboratories Limited: Key Employees Table 82: Aurobindo Pharma Ltd: key facts Table 83: Aurobindo Pharma Ltd: Annual Financial Ratios Table 84: Aurobindo Pharma Ltd: Key Employees Table 85: Sanofi SA: key facts Table 86: Sanofi SA: Annual Financial Ratios Table 87: Sanofi SA: Key Employees Table 88: Sanofi SA: Key Employees Continued Table 89: Genomma Lab Internacional SAB de CV: key facts Table 90: Genomma Lab Internacional SAB de CV: Annual Financial Ratios Table 91: Genomma Lab Internacional SAB de CV: Key Employees Table 92: Pfizer Inc.: key facts Table 93: Pfizer Inc.: Annual Financial Ratios Table 94: Pfizer Inc.: Key Employees Table 95: Pfizer Inc.: Key Employees Continued Table 96: Maypo Farmaceutics SA de CV: key facts
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
MarketLine 社の最新刊レポート本レポートと同じKEY WORD(competitive analysis)の最新刊レポートよくあるご質問MarketLine社はどのような調査会社ですか?マーケットライン(MarketLine)は、世界の産業および企業を国別や業種別に詳細に調査し、調査レポートを積極的に出版しています。また世界の企業を幅広く対象に様々な角度から調査した企業レポートも出版... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/09 10:27 143.78 円 159.73 円 191.51 円 |